Yayın:
Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy

dc.contributor.authorBehiye Şenel
dc.contributor.authorŞENEL, BEHİYE
dc.contributor.authorEbru Başaran
dc.contributor.authorBAŞARAN, EBRU
dc.contributor.authorEvrim Akyıl
dc.contributor.authorAkyıl, Evrim
dc.contributor.authorUmay Merve Güven
dc.contributor.authorBÜYÜKKÖROĞLU, GÜLAY
dc.contributor.authorGülay Büyükköroğlu
dc.contributor.orcid0000-0001-9747-8307
dc.contributor.orcid0000-0003-2104-2069
dc.contributor.orcid0000-0003-1547-0817
dc.contributor.orcid0000-0002-5089-6007
dc.date.accessioned2025-11-13T10:27:39Z
dc.date.issued2024-02-27
dc.identifier.doi10.1021/acsomega.3c09098
dc.identifier.endpage11685
dc.identifier.issn2470-1343
dc.identifier.issue10
dc.identifier.openalexW4392193677
dc.identifier.pubmed38496987
dc.identifier.scopus2-s2.0-85187546477
dc.identifier.startpage11671
dc.identifier.urihttps://hdl.handle.net/11421/4218
dc.identifier.urihttps://doi.org/10.1021/acsomega.3c09098
dc.identifier.volume9
dc.identifier.wos001176026500001
dc.language.isoen
dc.relation.ispartofACS Omega
dc.rightsopenAccess
dc.subjectDocetaxel
dc.subjectCancer therapy
dc.subjectMedicine
dc.subjectCancer
dc.subjectCancer research
dc.subjectOncology
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleCo-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5076726809
local.authorid.openalexA5076682992
local.authorid.openalexA5094011783
local.authorid.openalexA5039206093

Dosyalar

Koleksiyonlar